Most Continuing Medical Education (CME) is funded by pharma and filled with subtle marketing messages. Choosing pharma-free education maximizes the chances of receiving objective medical information. PharmedOut, a Georgetown University Medical Center rational prescribing project, and Kaiser Permanente collaborated on the creation of two new pharma-free CME activities. “How Industry Promotion Affects Prescribing” focuses on covert methods of promoting drugs, and “Mild Cognitive Impairment and Alzheimer’s Disease: First, do no harm” provides a critical assessment of therapies for dementia and mild cognitive impairment, as well as sensible alternatives. These courses can be viewed at: https://sites.google.com/georgetown.edu/pharmedout/cme. To learn more about PharmedOut and their approach to rational prescribing, please visit their website.
Partner Spotlight: PharmedOut
Kaiser Permanente is proud to partner with the Program on Regulation, Therapeutics, and Law (PORTAL), out of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital/Harvard Medical School, to uncover trends in pharmaceutical evidence generation and highlight the clinical benefits associated with newly approved drugs. Through this partnership, the PORTAL team has published five prominent peer-reviewed studies so far.